|
May 17
|
J&J (JNJ) to Boost Dermatology Portfolio With New Acquisition
|
|
May 16
|
Johnson & Johnson To Acquire Early-Stage Eczema Treatment Developer Proteologix For $850M
|
|
May 16
|
Johnson & Johnson to Buy Proteologix For $850 Million in Cash
|
|
May 16
|
Johnson & Johnson (JNJ) Up 5.5% Since Last Earnings Report: Can It Continue?
|
|
May 16
|
UPDATE 1-Johnson & Johnson to acquire Proteologix for $850 million
|
|
May 16
|
Johnson & Johnson to acquire Proteologix for $850 million
|
|
May 16
|
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
|
|
May 16
|
J&J to buy Proteologix and its dual-targeting antibody drugs for $850M
|
|
May 15
|
1 No-Brainer Growth Stock to Buy and Hold for 10 Years
|
|
Jan 16
|
20 Worst States for Dividend Income Investors
|
|
Jan 14
|
3 Super-Safe High-Yield Dividend Stocks You Can Buy Right Now
|
|
Jan 14
|
2 Former Warren Buffett Stocks That Stand Out as Stong Buys in 2024
|
|
Jan 13
|
2 Average Stocks That Could Make You Rich
|
|
Jan 11
|
The Zacks Analyst Blog Highlights Johnson & Johnson, Micron Technology, The Southern Company, TotalEnergies and PACCAR
|
|
Jan 11
|
Walgreens Cut Its Dividend by 48%: Here Are 5 Better Dow Dividend Stocks to Buy in January
|
|
Jan 11
|
Johnson & Johnson Insiders Sold US$5.6m Of Shares Suggesting Hesitancy
|
|
Jan 11
|
2 Dow Stocks to Buy Hand Over Fist in 2024 and 1 to Avoid Like the Plague
|
|
Jan 10
|
3 Unshakeable Dividend Stocks for Lifelong Wealth
|
|
Jan 10
|
Top Analyst Reports for Johnson & Johnson, Micron Technology & Southern Company
|
|
Jan 10
|
Will Q4 Earnings Push Dow ETF Higher?
|